Not if the next report echo's the last with $2m cost to make $1.3m in revenueNew product line with only increase expenses. Will trade the chart though and take each crumb where I can
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor